Publications

Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications
Stone M, Grebe PE, Sulaeman H, Germanio CD, Dave H, Kelly K, Biggerstaff BJ, Crews BO, Tran N, Jerome KR, Deny TN, Hogema B, Jones JM, Thornburg NJ, Simmons G, Krajden M, Kleinman S, Dumont LJ, Busch MP

https://wwwnc.cdc.gov/eid/article/28/3/21-1885_article

(2022)

https://doi.org/10.3201/eid2803.211885
Classification schemes of COVID-19 high risk areas and resulting policies: a rapid review
Uthman O, Adetokunboh OO, Wiysonge CS, Al-Awlaqi S, Hanefeld J, El Bcheraoul C

Frontiers in Public Health

(2022)

https://doi.org/10.3389/fpubh.2022.769174
Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo
Pearson CAB, Edmunds WJ, Hladish TJ, Eggo RE

International Journal of Epidemiology

(2022)

https://doi.org/10.1093/ije/dyab172
Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021
Cable R, Coleman C, Glatt T, Grebe PE, Mhlanga L, Nyano C, Pieterson N, Swanevelder R, Swarts A, Sykes W, van den Berg K, Vermeulen M, Welte A

medRxiv

(2022)

https://doi.org/10.21203/rs.3.rs-1359658/v1
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19
Makoah NA, Tipih T, Litabe MM, Brink M, Sempa JB, Goedhals D, Burt FJ

Future Virology

(2022)

https://doi.org/10.2217/fvl-2021-0211
Prolonged-course tuberculosis treatment or secondary prevention for those at high risk of recurrence?
Moore DP, Hesseling AC, Marx FM

Clinical Infectious Diseases

(2022)

https://doi.org/10.1016/j.cmi.2022.01.013
Cervical cancer in women living in South Africa: a record linkage study of the National Health Laboratory Service and National Cancer Registry
Dhokotera T, Asangbeh S, Bohlius J, Singh E, Egger M, Rohner E, Ncayiyana J, Clifford Gm, Olago V, Muchengeti MM

ecancermedicalscience

(2024)

https://doi.org/10.3332/ecancer.2022.1348
The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 – September 2021
Perofsky AC, Tempia S, Bingham JL, Maslo C, Toubkin M, Laubscher A, Walaza S, Pulliam JRC, Viboud C, Cohen C

Clinical Infectious Diseases

(2022)

https://doi.org/10.1093/cid/ciac055
Human immunodeficiency virus funding and access to treatment in sub-Saharan Africa
Granich R, Gupta S, Williams BG

International Journal of STD & AIDS

(2022)

https://doi.org/10.1177/09564624211042287
Use of interactive messaging to reduce pre-diagnosis loss to follow-up for TB care
Marx FM, Meehan SA, Jivan D, Dunbar R, Hoddinott G, Hesseling AC, Osman M

The International Journal of Tuberculosis and Lung Disease

(2022)

https://doi.org/10.5588/ijtld.21.0332
Spatially targeted digital chest radiography to reduce tuberculosis in high-burden settings: a study of adaptive decision making
de Villiers AK, Dye D, Yaesoubi R, Cohen T, Marx FM

Epidemics

(2022)

https://doi.org/10.1016/j.epidem.2022.100540
Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa
Pearson CAB, Silal SP, Li MWZ, Dushoff J, Bolker BM, Abbott S, van Schalkwyk C, Davies NG, Barnard RC, Edmunds WJ, Bingham JL, Meyer-Rath G, Glass A, Wolter N, Govender N, Stevens W, Scott L, Mlisana K, Moultrie H, Pulliam JRC

medRxiv

(2021)

https://doi.org/10.1101/2021.12.19.21268038
Mapping routine measles vaccination in low- and middle-income countries
Sbarra AN, Rolfe S, Nguyen JQ, Earl L, Galles NC, Marks A, Abbas KM, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, Abdelalim A, Abdollahi M, Abegaz KH, Abiy HAA, Abolhassani H, Abreu LG, Abrigo MRM, Abushouk AI, Accrombessi MMK, Adabi M, Adebayo OM, Adekanmbi V, Adetokunboh OO, et al

Nature

(2021)

https://doi.org/10.1038/s41586-020-03043-4
Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries
Torres-Rueda S, Sweeney S, Bozzani F, Naylor NR, Baker T, Pearson CAB, Eggo R, Procter SR, Davies N, Quaife M, Kitson N, Keogh-Brown MR, Jensen HT, Saadi N, Khan M, Huda M, Kairu A, Zaidi R, Barasa E, Jit M, Vassall A

BMJ Global Health

(2021)

https://doi.org/10.1136/bmjgh-2021-005759
Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries – a model-based cost-effectiveness analysis
Marx FM, Hauer B, Menzies NA, Haas W, Perumal N

BMC Public Health

(2021)

https://doi.org/10.1186/s12889-021-12142-4
Inferring HIV transmission network determinants using agent-based models calibrated to multi-data sources
Niyukuri D, Chibawara T, Nyasulu PS, Delva W

MC Pregnancy & Childbirth

(2021)

https://doi.org/10.3390/math9212645
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
Kinyoki D, Osgood-Zimmerman AE, Bhattacharjee NV, Kassebaum NJ, Hay SI, et al

Nature Medicine

(2021)

https://doi.org/10.1038/s41591-021-01498-0
Smoothing age/time structure of HIV prevalence, for optimal use in synthetic cohort based incidence estimation
Mhlanga L, Grebe PE, Welte A

medRxiv

(2021)

https://doi.org/10.21203/rs.3.rs-959136/v1
Mind the gap: patterns of red blood cell product usage in South Africa, 2014 – 2019
Bolton L, van den Berg K, Swanevelder R, Pulliam JRC

The South African Medical Journal

(2021)

https://doi.org/10.7196/SAMJ.2021.v111i10.15658
COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness
Pearson CAB, Bozzani F, Procter SR, Davies NG, HudaI M, Jensen HT, Keogh-Brown M, Khalid M, Sweeney S, Torres-Rueda S, CHiL COVID-19 Working Group, CMMID COVID-19 Working Group, Eggo RM, Vassall A, Jit M

PLoS Medicine

(2021)

https://doi.org/10.1371/journal.pmed.1003815
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease
Migliori GB, Marx FM, Ambrosino N, Zampogna E, Schaaf HS, van der Zalm MM, Allwood BW, Byrne AL, Mortimer K, Wallis RS, Fox GJ, Leung CC, Chakaya JM, Seaworth B, Rachow A, Marais BJ, Furin J, Akkerman OW, Al Yaquobi F, Amaral AFS, Borisov S, Caminero JA, Carvalho ACC, Chesov D, Codecasa LR, Teixeira RC, Dalcolmo MP, Datta S, Dinh-Xuan AT, Duarte R, Evans CA, Garcia Calleja JM, GÃ¼nther G, Hoddinott G, Huddart S, Ivanova O, Laniado-LaborÃn R, Manga S, Manika K, Mariandyshev A, Mello FCQ, Mpagama SG, MuÃ±oz-Torrico M, Nahid P, Ong CWM, Palmero DJ, Piubello A, Pontali E, Silva DR, Singla R, Spanevello A, Tiberi S, Udwadia ZF, Vitacca M, Centis R, DÂ´Ambrosio L, Sotgiu G, Lange C, Visca D

The International Journal of Tuberculosis and Lung Disease

(2021)

https://doi.org/10.5588/ijtld.21.0425
Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response
Azam JM, Saitta B, Bonner K, Ferrari MJ, Pulliam JRC

Vaccine

(2021)

https://doi.org/10.1016/j.vaccine.2021.08.053
Influence of sexual risk behaviour and STI co-infection dynamics on the evolution of HIV set point viral load in MSM
Hendrickx DM, Delva W, Hens N

Epidemics

(2021)

https://doi.org/10.1016/j.epidem.2021.100474
Four-week forecasts of COVID-19 epidemic trajectories in South Africa, Chile, Peru and Brazil: a model evaluation
Delva W, Dominic EM, Beauclair RN, Ouifki R, Kroon M, Volmink H, Dorkin E

medRxiv

(2021)

https://doi.org/10.1101/2021.09.06.21263151
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
Paulson KR, Kamath AM, Alam T, Bienhoff K, Abady GG, Abbas J, Abbasi-Kangevari M, Adetokunboh OO, et al

The Lancet

(2021)

https://doi.org/10.1016/S0140-6736(21)01207-1

Previous 456 Next

Publications

Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications

Classification schemes of COVID-19 high risk areas and resulting policies: a rapid review

Potential test-negative design study bias in outbreak settings: application to Ebola vaccination in Democratic Republic of Congo

Estimates of prevalence of anti-SARS-CoV-2 antibodies among blood donors in eight provinces of South Africa in November 2021

A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19

Prolonged-course tuberculosis treatment or secondary prevention for those at high risk of recurrence?

Cervical cancer in women living in South Africa: a record linkage study of the National Health Laboratory Service and National Cancer Registry

The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 – September 2021

Human immunodeficiency virus funding and access to treatment in sub-Saharan Africa

Use of interactive messaging to reduce pre-diagnosis loss to follow-up for TB care

Spatially targeted digital chest radiography to reduce tuberculosis in high-burden settings: a study of adaptive decision making

Bounding the levels of transmissibility & immune evasion of the Omicron variant in South Africa

Mapping routine measles vaccination in low- and middle-income countries

Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries

Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries – a model-based cost-effectiveness analysis

Inferring HIV transmission network determinants using agent-based models calibrated to multi-data sources

Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018

Smoothing age/time structure of HIV prevalence, for optimal use in synthetic cohort based incidence estimation

Mind the gap: patterns of red blood cell product usage in South Africa, 2014 – 2019

COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness

Clinical standards for the assessment, management and rehabilitation of post-TB lung disease

Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response

Influence of sexual risk behaviour and STI co-infection dynamics on the evolution of HIV set point viral load in MSM

Four-week forecasts of COVID-19 epidemic trajectories in South Africa, Chile, Peru and Brazil: a model evaluation

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

Type

Year

Author